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2013 to May 2015 in a tertiary care hospital in rural India aimed to evaluate the risk factors, 
treatment, outcome, and complications of Clostridium difficile infections in hospitalized patients. 
Materials and Methods: The study involved a total of 183 patients, of which 61 were cases, and 
122 were controls. Data was analyzed using multivariate logistic regression. Results: Antibiotic 
intake in the past four weeks (p=0.003), hypoalbuminemia (p=0.001) and duration of hospital 
stay before the onset of diarrhea (p<0.001) were proven to have significant risk. We subdivided 
cases into severe and non-severe cases, and we found that complications were statistically higher 
in severe cases (OR= 1.685, <0.001). Conclusion: Identifying severe cases and administering 
timely and appropriate treatment is prudent.
INTRODUCTION
Clostridium difficile  is  a  strictly  anaerobic, Gram-positive, 
spore-forming bacterium. Clinical manifestations of human 
C. difficile infections are due to toxins (A and B) produced 
by pathogenic strains of C. difficile (1).
In some hospitals, Methicillin-resistant Staphylococcus 
aureus has been surpassed by hospital-acquired Clostridium 
difficile infection (CDI) as the leading source of healthcare-as-
sociated infection, and because of its significant morbidity and 
mortality, CDI has been of concern over the last decade (2).
Antibiotic  use  which  disrupts  the microbiota  increases 





to determine risk factors associated with CDI among patients 
with hospital-acquired diarrhea and with poor prognosis in a 
tertiary care hospital.
MATERIALS AND METHODS
This  study was  conducted  in Kasturba Hospital,  a  tertiary 
care  hospital  in  Manipal,  Karnataka,  India  from  October 
2013 to May 2015. The study applied a mixed study design 








Bristol Score type 7) after a minimum of 48 hours of hospital 
stay and who were tested for Clostridium difficile by rapid 
test and/or ELISA and/or stool culture. Patients with laxative 
intake in the last 48 hours were excluded from the study. 




Amongst patients who developed diarrhea after 48 hours 
of hospital stay, those who tested positive for CDI were con-
sidered cases while those who tested negative for CDI were 
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(>6/day),  hypoalbuminemia  (serum  albumin<25g/L)  each 
given one point and presence of radiological signs, given 2 





for the social sciences (SPSS) version 20. All independent vari-
ables with values <0.05 in the univariate analysis were includ-
ed in stepwise multiple logistic regression to identify factors 
associated with CDI among patients with hospital-acquired di-
arrhoea. In the multivariate model, independent variables were 
eliminated from the highest to the lowest value but remained 
in the model if their value was <0.05. The Odds ratios (ORs) 
were estimated along with the 95% confidence intervals (CIs).
RESULTS
This study involved a total of 183 patients, of which 61 were 
cases, and 122 were controls. The mean age was 49.77 in 
cases and 40.53 in controls. Further demographic character-
istics of the respondents are given in Table 2.
Ninety-four controls (77.04%) and 10 cases (16.39%) 
had a hospital stay prior to the onset of diarrhea of less than 
one week. Twenty-four controls (19.67%) and 40 cases 
(65.57%) had a hospital stay between one and three weeks 
(p<0.001). Four controls (3.27%) and 11 cases (18.03%) had 
been admitted in the hospital for ≥ three weeks (p<0.001). 
27 cases (44.3%) underwent recent surgery, as compared to 
27 controls (22.1%) (p=0.002).
The Charlson comorbidity index interquartile range was 
3 for cases and 2 for controls.
The median number of days of gastric suppression thera-
py in cases was 14 and was 4 in controls. Other risk factors 
for CDI are given in Table 3.
Multivariate logistic regression (Table 4) showed that 
history of antibiotic intake in the past four weeks (p=0.003), 




Leukocytosis  was  a  significant  marker  for  severity 
(p<0.005); 68.9% of cases had leukocytosis as compared to 
39.3 % controls. (Table 5)
Of the 61 cases, 21 had a fever while 56 of the 122 controls 
had a fever. AKI was present in 15 out of 61 cases, and 19 out 
of 122 of controls had AKI. Neither p-value was significant.
Amongst the 61 patients with C. difficile infection, antibi-
otics were withdrawn in 37 of them. A single antibiotic was 
used to treat 18 of them, 16 were treated only with metro-
nidazole and 2 with only vancomycin; 43 were treated with 
both vancomycin and metronidazole.
Hyponatremia  (Na+<135 mmol/L) and hypokalemia 
(K+< 3.5 mmol/L) were some of the observed electrolyte im-
balances. Further analyses  indicated  that 55.7% developed 
hyponatremia and 42.6% developed hypokalemia amongst 
the cases whereas in controls, only 24.6% had hyponatremia 
and 13.9% developed hypokalemia. Amongst the 61 cases, 
60.7% developed complications (p<0.001); 55.7% devel-
oped electrolyte imbalances (p<0.005) and 24.6% developed 
AKI. Controls, on the other hand, had a 25.4% rate of com-
plications; 24.6% had electrolyte imbalances, and 15.6% had 
AKI.
Of the cases 86.9% improved, 4.9% had recurrences, and 
8.2% expired. Amongst controls, 98.4% improved and 1.6% 
expired.
Subanalysis
The cases were divided into two groups for analysis; severe 
and  non-severe.  There  was  no  significant  difference  be-
tween severe and non- severe cases regarding relative risk 




Acute rise of creatinine levels 1 point
Stool count >6/day 1 point
Body temperature >38.3°C 1 point
Severe grade of radiological signs 2 points
WBC: White Blood Cell
Table 2. Patient characteristics
Characteristics Case % (n/N) Control % (n/N)
Age (mean age in years) 49.77 40.53
Female sex 44.3 (27/61) 34.4 (42/122)
The median duration of hospital stay before onset of 
diarrhoea (IQR)
14 (8-19) 4 (4-8)
Number of antibiotics used before the onset of diarrhea
0 1.6 (1/61) 37.7 (46/122)
1 21.3 (13/61) 19.7 (24/122)
2 21.3 (13/61) 17.2 (21/122)
3 19.7 (12/61) 13.1 (16/122)
4 23 (14/61) 11.5 (14/122)
5 or more 13.1 (8/61) 0.8 (1/122)
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for  antibiotic  intake  (p=0.693). 16.7 % of non-severe cas-
es were above  the age of 65 years, as compared  to 10.5% 
of severe cases. Severity of disease in cases did not show 
any co-relation with duration of the hospital stay [relative 
risk: <1 week- 1.131 (p=0.582); 1-3 weeks- 0.873 (p=NA); 




both  antibiotics  compared  to  66.6  %  of  non-severe  cas-
es. Metronidazole  as  a  single  agent was used  in 30.9% of 
non-severe cases. Complications were statistically more sig-
nificant  in severe cases (p<0.001). Up to 15.8 % of severe 
cases succumbed to the disease against 4.8% of non-severe 
cases (p=0.145). Recurrence was seen in 5.3% and 4.8% of 




tal in Karnataka had 61 cases and 122 controls.
Increasing age increases the risk as well as the severi-
ty of CDI (5, 6). Yang et al demonstrated age greater than 
70  years  (adjusted  odds  ratio  [OR],  1.76;  95% confidence 
interval [CI], 1.12 to 2.75; p=0.01),  to  be  an  independent 
risk factor for CDI (7). However, in this study, age was not 
a risk factor for the development of CDI nor a marker of 
severity of disease, as outbreaks probably occurred in wards 
with relatively younger age groups and only a few patients 
were aged above 65 years.
Although some studies, including Yang et al., have sug-
gested  that  female sex may be a predictor,  it  is difficult  to 
explain the relationship between sex and CDI (7, 8, 9).
Almost  all  antibiotics,  including  metronidazole  and 
vancomycin, can predispose to C. difficile. According to 
Khanafer et al., prior to CDI, 38 patients (95.0%) were ex-
posed  to  antibiotics,  and  12  (30%)  received  at  least  four 
antibiotics.  Fluoroquinolones,  3rd generation Cephalospo-
rins,  and  Co-amoxiclav  were  prescribed  most  frequently 
(65%, 55%, 40% and 37.5%, respectively) (10). Our study 
demonstrated  use  of  antibiotics  such  as  Cephalosporins 
(OR= 4.329, 95%CI, p<0.001), Amikacin (OR= 2.794, 95% 








Prior surgical procedure 0.983
Hypoalbuminemia 0.001
Duration of hospital Stay <0.001
Charlson comorbidity index 0.589
Gastric acid suppression 0.002
Table 4. Risk factors and their significance through multivariate logistic regression
Risk factors Cases (n=61) (%) Controls (n=122) (%) P value CI
Age>65 years 09 (14.8) 12 (9.8) 0.228 0.667 (0.297-1.495)
Details of antibiotics received
Penicillin 13 (21.7) 25 (32.9) 0.521 1.051 (1.922-7.140)
Cephalosporins 51 (85) 66 (86.8) <0.001 4.329 (2.012-9.306)
Amikacin 27 (45) 27 (35.5) 0.002 2.794 (1.442-5.416)
Trimethoprim/Sulphamethoxazole 18 (30) 12 (15.8) 0.001 3.837 (1.705-8.635)
Metronidazole  32 (53.3) 28 (36.8) <0.001 3.104 (1.922-7.140)
Table 5. Markers of severity in cases and controls
Markers Case % (n/N) Control % (n/N) Or value 95% CI p‑value
Fever (>38.3°C) 34.4 (21/61) 45.9 (56/122) 0.619 0.092
(0.327-1.170)
Leukocytosis (15×109/L) 68.9 (42/61) 39.3 (48/122) 3.408 <0.001
(1.775-6.543)
Hypoalbuminemia (<25g/L) 36.1 (22/61) 10.6 (13/122) 0.211 <0.001
(0.097-0.459)
AKI 24.6 (15/61) 15.6 (19/122) 1.767 0.138
(0.825-3.782)












Increased length of hospital stay prior to the onset of 
diarrhoea was  found  to be  statistically  significant with  the 
development of CDI in our study (p<0.005), which was in 
accordance with  previous  observational  studies  as  demon-
strated by Freeman et al. and Morrison et al. (11, 12). This 
could  be  due  to  multiple  reasons:  prolonged  exposure  to 
spore-bearing bacilli, use of antibiotics, use of PPIs and other 
comorbidities (11, 12). As previously mentioned, increased 
risk of CDI was seen with surgical procedures. Among pa-
tients with preoperative prophylaxis (PAP), the risk of CDI 
was 14.9 cases per 1000 surgical procedures (5). According 
to McCarter et al., regardless of the surgical procedure, for 
pretreated patients, the risk of CDI was 4.2 times higher than 
that of the control group (13). Our study also showed an in-
creased risk of CDI in patients who had undergone a surgical 
procedure,  which  was  statistically  significant  (OR=2.794, 
95% CI, p=0.002).
Dial et al. estimated an adjusted risk ratio for CDI with 




tributed this to the acid resistance of C. difficile spores (15). 
Patients on PPIs are 4.17 times more likely to develop CDI 
compared to patients, not on PPIs (16). Based on analysis of 
gastric contents of patients on PPIs, Jump found that vege-
tative C. difficile survival increased at a pH of >5 (17). We 
compared  the median  number  of  days  for  the  exposure  to 
gastric acid suppression before the onset of diarrhoea. The 
cases had 14 days (IQR [Interquartile Range] = 8-19) while 




were given PPIs. PPIs are associated with increased risk of 
CDI most likely because it decreases the barrier to coloniza-
tion by vegetative forms of C. difficile (14, 18).
Charlson  Co-morbidity  index  was  calculated  in  recent 
CDI  studies  since  previous  observational  studies  found 
co-morbidities  like  diabetes,  cancer,  HIV  to  be  indepen-
dent risk factors. Kurti et al, showed significant association 
with Charlson  co-morbidity  index  (p= 0.004) (19). In this 
study, we observed a similar picture, with the index being 3 
(IQR= 2-4) in cases while in controls it was 2 (IQR= 2-3) 
(OR= 1.504, 95% CI, p<0.001).
Amongst the risk factors, after initial univariate analysis, 






ration of hospital stays (p<0.001) and gastric acid suppres-
sion (p=0.002) were significant.
In our study we compared cases to controls in accordance 
with Zar et al., we found a statistically significant associa-
tion  between  leukocytosis  (OR= 3.408,  95% CI, p<0.005) 




to  facilitate  regeneration  of  the  normal  gut microflora. An 
antibiotic with  activity  against C. difficile  should  be  start-
ed. Initial therapies based on the severity of disease include 
metronidazole  for  mild-moderate  disease,  vancomycin  for 
severe disease or a combination of the two for severe-com-
plicated disease  (20).  In a  recent study by Khanafer et al., 
metronidazole was administered as a single agent to 25 pa-
tients, vancomycin to 2 (5%), 2 CDI medications to 8 (20%) 
and no antimicrobials against CDI to 5 (10).






tomies, and deaths related to CDI [21]. In our study, com-
plications (OR=4.526, p <0.001) and electrolyte imbalance 
(OR= 3.826, p<0.001) were found to be significantly more 
in cases when compared to controls. Further, it was seen that 
86.9 % (53/61) patients improved clinically and recurrence 
was observed in only 4.9% (3/61) while 0.08% (5/61) cases 
expired of which three died primarily of complications relat-
ed to CDI. Identifying patients who are at high risk for se-
vere CDI early during infection may direct therapy and help 





ed cases into severe and non-severe cases using the severity 
score parameters as previously described and analyzed it for 
relative risk for each risk factor. In the previous studies, such 
categorization between cases based on severe and non- severe 
cases was only made for deciding the treatment options (22).
There was no difference in treatment strategies between 
the severe and non- severe group. This study involved 31.1% 
(19/61) severe and 68.9% (42/61) non-severe CDI, and there 
was no statistically significant difference for all the risk fac-
tors  previously  discussed  between  severe  and  non-severe 
groups. Also, there was no difference in the treatment of-
fered to either group. Patients in the severe group had sig-
nificantly  high  complication  rates  (OR=  1.685,  p<0.001). 
Amongst patients with severe disease, 15 (78.9%) recovered 
while 38 (90.4%) with non-severe disease improved. Recur-
rence was seen in one (5.3%) of the severe cases and two 
(4.8%) of the non-severe cases, while three (15.8%) severe 
cases died as against two (4.8%) non-severe cases.
Some of the limitations of this study include the fact 
that  the study was related to  the single-center observation-
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al  design. Also,  selection  bias  is  a  possibility  because  the 
selection of controls is often challenging. Further, age and 
sex matching could not be done as both were pre-identified 
individual predictors of CDI.
CONCLUSION
In conclusion, Clostridium difficile infection is an important 
cause of morbidity and mortality and should be suspected in 
all cases of hospital-acquired diarrhea. Some of the risk factors 
for CDI  include  antibiotic  intake,  gastric  acid  suppression, 
hypoalbuminemia  and  prolonged  hospital  stay.  Compli-
cations are frequent in severe cases and hence the need for 
identifying these cases for timely institution of appropriate 
treatment. Lastly, inpatient hospital outbreaks of CDI should 
be prevented by proper  isolation of  the  index case, contact 
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